Company intelligence / Profile preview

MarisOmega

Kristiansund, Norway

Ownership: Private
Development stage: Other

Overview

MarisOmega is a Norwegian biotechnology company specializing in the development and production of high-quality marine-derived omega-3 fatty acids. The company focuses on sustainable sourcing and advanced purification techniques to provide premium fish oil concentrates for the pharmaceutical and nutraceutical industries. Their product portfolio is designed to support cardiovascular health, reduce inflammation, and promote cognitive function through highly bioavailable lipid formulations. MarisOmega leverages Norway's extensive maritime expertise to ensure traceability and environmental responsibility throughout its supply chain.

Therapeutic areas: CardiovascularImmunologyNeurology
Modalities: Small moleculeLipids
Industry: Chemicals & Materials

Beyond the preview

Go deeper on MarisOmega.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MarisOmega.

Explore the full profile